Two Treatments for Retinitis Pigmentosa Move Closer to Clinical Trials

News   Dec 21, 2012

 
Two Treatments for Retinitis Pigmentosa Move Closer to Clinical Trials
 
 
 

RELATED ARTICLES

Agent Reverses Resistance to Targeted Drug in Some Leukemias

News

After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.

READ MORE

Immune Response Restored in Patients with Melanoma Thanks to New Compound

News

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.

READ MORE

Targeted Antisense Treatment of APOE4 Reduces Alzheimer's Damage

News

Novel antisense oligonucleotide interferes with the instructions for building the APOE protein and reduces pathophysiology of AD.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE